(Q40198081)

18 September 2017

Duration of post-vaccination immunity against yellow fever in adults (English)

1 reference

18 September 2017

0 references

1 reference

Collaborative group for studies on yellow fever vaccines

series ordinal

1

1 reference

PubMed ID

25090646

18 September 2017

language of work or name

English

0 references

publication date

29 July 2014

1 reference

18 September 2017

1 reference

18 September 2017

32

1 reference

18 September 2017

39

1 reference

18 September 2017

4977-4984

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.021

18 September 2017

1 reference

Efficacy and duration of immunity after yellow fever vaccination: systematic review on the need for a booster every 10 years.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.021

Evaluation of accuracy and reliability of the plaque reduction neutralization test (micro-PRNT) in detection of yellow fever virus antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.021

WINPEPI updated: computer programs for epidemiologists, and their teaching potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.021

Yellow fever vaccination: is one dose always enough?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.021

Yellow fever revaccination guidelines change - a decision too feverish?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.021

Immunogenicity of WHO-17D and Brazilian 17DD yellow fever vaccines: a randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.021

Assessment of IgG antibodies against yellow fever virus after vaccination with 17D by different assays: neutralization test, haemagglutination inhibition test, immunofluorescence assay and ELISA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.021

Long term persistence of yellow fever neutralising antibodies in elderly persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.021

Description of a prospective 17DD yellow fever vaccine cohort in Recife, Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.021

17DD yellow fever vaccine: a double blind, randomized clinical trial of immunogenicity and safety on a dose-response study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.021

10.1016/J.VACCINE.2014.07.021

7 January 2021

Identifiers

DOI

1 reference

18 September 2017

1 reference

PubMed ID

25090646